Engineering immunoproteasome-expressing mesenchymal stromal cells: A potent cellular vaccine for lymphoma and melanoma in mice

Dendritic cells (DCs) excel at cross-presenting antigens, but their effectiveness as cancer vaccine is limited. Here, we describe a vaccination approach using mesenchymal stromal cells (MSCs) engineered to express the immunoproteasome complex (MSC-IPr). Such modification instills efficient antigen c...

Descripción completa

Detalles Bibliográficos
Autores principales: Abusarah, Jamilah, Khodayarian, Fatemeh, El-Hachem, Nehme, Salame, Natasha, Olivier, Martin, Balood, Mohammad, Roversi, Katiane, Talbot, Sebastien, Bikorimana, Jean-Pierre, Chen, Jingkui, Jolicoeur, Mario, Trudeau, Louis-Eric, Kamyabiazar, Samaneh, Annabi, Borhane, Robert, Francis, Pelletier, Jerry, El-Kadiry, Abed-El-Hakim, Shammaa, Riam, Rafei, Moutih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714858/
https://www.ncbi.nlm.nih.gov/pubmed/35028603
http://dx.doi.org/10.1016/j.xcrm.2021.100455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714858/
https://www.ncbi.nlm.nih.gov/pubmed/35028603
http://dx.doi.org/10.1016/j.xcrm.2021.100455

Ejemplares similares